Dishman Carbogen Amcis Ltd Hits Intraday Low Amid Price Pressure on 4 Feb 2026

Intraday Price Movement and Volatility

The stock opened with a gap down of 7.16%, signalling early bearish sentiment among traders. Throughout the trading session, Dishman Carbogen Amcis Ltd exhibited high volatility, with an intraday volatility measure of 87.53% based on the weighted average price. This level of price fluctuation is notably elevated, indicating active trading and uncertainty among market participants.

After two consecutive days of gains, the stock reversed course decisively, closing well below its opening price. The intraday low of Rs 203.1 represents a 11.06% decline from the previous close, underscoring the intensity of the price pressure faced today.

Comparison with Sector and Market Benchmarks

Dishman Carbogen Amcis Ltd’s performance today was markedly weaker than its Pharmaceuticals & Biotechnology sector peers, underperforming the sector by 10.07%. While the Sensex index rebounded sharply after an initial negative opening—recovering 605.47 points to trade at 83,857.53, a gain of 0.14%—Dishman Carbogen Amcis Ltd moved in the opposite direction, declining by 10.16% on the day.

This divergence highlights the stock’s relative weakness amid a broadly positive market environment. Over the past week, the stock has marginally declined by 0.44%, while the Sensex gained 1.84%. The one-month trend is more pronounced, with Dishman Carbogen Amcis Ltd falling 19.55% compared to the Sensex’s 2.22% decline. The three-month performance shows a 30.96% drop for the stock, contrasting with a modest 0.48% gain in the benchmark index.

Technical Indicators and Moving Averages

From a technical standpoint, Dishman Carbogen Amcis Ltd is trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages. This broad-based weakness across short, medium, and long-term trend indicators suggests sustained downward momentum in the stock price.

The stock’s Mojo Score currently stands at 17.0, with a Mojo Grade of Strong Sell, upgraded from a previous Sell rating on 12 Jan 2026. This grading reflects a deteriorated outlook based on the latest financial and market data assessments. The Market Cap Grade remains low at 3, indicating limited market capitalisation strength relative to peers.

Longer-Term Performance Context

Examining the stock’s performance over extended periods reveals a mixed picture. While the three-year return remains robust at 146.87%, significantly outperforming the Sensex’s 37.83% gain, more recent trends have been less favourable. The one-year return is negative at -16.09%, compared to a positive 6.71% for the Sensex. Year-to-date, the stock has declined 17.24%, underperforming the Sensex’s 1.60% loss.

These figures indicate that despite strong historical gains over several years, the stock has faced increasing headwinds in the near term, reflected in its recent price declines and technical weakness.

Market Sentiment and Immediate Pressures

Despite a broadly positive market environment, with the Sensex recovering from an early loss and trading close to its 52-week high, Dishman Carbogen Amcis Ltd faced distinct selling pressure. The stock’s underperformance relative to mega-cap leaders and the broader index suggests company-specific factors or sector-related concerns are weighing on investor sentiment.

The high intraday volatility and gap down opening indicate that traders reacted swiftly to negative cues, resulting in a sharp price correction. The stock’s failure to sustain gains from the previous two days further emphasises the prevailing caution among market participants.

Overall, the combination of technical weakness, negative short-term price action, and relative underperformance against sector and market benchmarks has contributed to the stock hitting its intraday low and closing with a substantial loss on 4 Feb 2026.

Summary

Dishman Carbogen Amcis Ltd’s trading session on 4 Feb 2026 was characterised by significant price pressure and volatility. The stock’s intraday low of Rs 203.1 marked an 11.06% decline, with a gap down opening and underperformance relative to the Pharmaceuticals & Biotechnology sector and the Sensex. Technical indicators remain weak, with the stock trading below all major moving averages and holding a Strong Sell Mojo Grade. Despite a positive market backdrop, the stock faced immediate selling pressure, reflecting cautious sentiment and a challenging near-term outlook.

Upgrade at special rates, valid only for the next few days. Claim Your Special Rate →